1. 272 Acute phase reactant levels and prednisone doses at disease flare in patients with giant cell arteritis: prospective data from the GiACTA trial. (12th April 2019) Authors: Stone, John H; Tuckwell, Katie; Dimonaco, Sophie; Klearman, Micki; Aringer, Martin; Blockmans, Daniel; Brouwer, Elisabeth; Cid, Maria C; Dasgupta, Bhaskar; Rech, Juergen; Salvarani, Carlo; Schulze-Koops, Hendrik; Schett, Georg; Spiera, Robert; Unizony, Sebastian H; Collinson, Neil Journal: Rheumatology Issue: Volume 58(2019)Supplement 3 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 351. EFFECTS OF BASELINE PREDNISONE DOSE ON REMISSION AND DISEASE FLARE IN PATIENTS WITH GIANT CELL ARTERITIS TREATED WITH TOCILIZUMAB IN A PHASE 3 RANDOMIZED CONTROLLED TRIAL. (29th March 2019) Authors: Stone, John; Tuckwell, Katie; Dimonaco, Sophie; Klearman, Micki; Aringer, Martin; Blockmans, Daniel; Brouwer, Elisabeth; Cid, Maria; Dasgupta, Bhaskar; Rech, Juergen; Salvarani, Carlo; Schulze-Koops, Hendrik; Schett, Georg; Spiera, Robert; Unizony, Sebastian; Collinson, Neil Journal: Rheumatology Issue: Volume 58(2019)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. An Evaluation of Risk Factors for Major Adverse Cardiovascular Events During Tocilizumab Therapy. Issue 2 (February 2015) Authors: Rao, Vijay U.; Pavlov, Andrey; Klearman, Micki; Musselman, David; Giles, Jon T.; Bathon, Joan M.; Sattar, Naveed; Lee, Janet S. Journal: Arthritis & rheumatology Issue: Volume 67:Issue 2(2015) Page Start: 372 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Cardiovascular Safety of Tocilizumab Versus Etanercept in Rheumatoid Arthritis: A Randomized Controlled Trial. Issue 1 (27th December 2019) Authors: Giles, Jon T.; Sattar, Naveed; Gabriel, Sherine; Ridker, Paul M.; Gay, Steffen; Warne, Charles; Musselman, David; Brockwell, Laura; Shittu, Emma; Klearman, Micki; Fleming, Thomas R. Journal: Arthritis & rheumatology Issue: Volume 72:Issue 1(2020) Page Start: 31 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Cardiovascular Safety of Tocilizumab Versus Tumor Necrosis Factor Inhibitors in Patients With Rheumatoid Arthritis: A Multi‐Database Cohort Study. Issue 6 (28th April 2017) Authors: Kim, Seoyoung C.; Solomon, Daniel H.; Rogers, James R.; Gale, Sara; Klearman, Micki; Sarsour, Khaled; Schneeweiss, Sebastian Journal: Arthritis & rheumatology Issue: Volume 69:Issue 6(2017) Page Start: 1154 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Comparison of lipid and lipid-associated cardiovascular risk marker changes after treatment with tocilizumab or adalimumab in patients with rheumatoid arthritis. Issue 10 (27th November 2015) Authors: Gabay, Cem; McInnes, Iain B; Kavanaugh, Arthur; Tuckwell, Katie; Klearman, Micki; Pulley, Jennifer; Sattar, Naveed Journal: Annals of the rheumatic diseases Issue: Volume 75:Issue 10(2016) Page Start: 1806 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Development and Implementation of a Double-Blind Corticosteroid-Tapering Regimen for a Clinical Trial. (24th March 2015) Authors: Collinson, Neil; Tuckwell, Katie; Habeck, Frank; Chapman, Monique; Klearman, Micki; Stone, John H. Other Names: Kawai Shinichi Academic Editor. Journal: International journal of rheumatology Issue: Volume 2015(2015) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Glucocorticoid Dosages and Acute‐Phase Reactant Levels at Giant Cell Arteritis Flare in a Randomized Trial of Tocilizumab. Issue 8 (3rd July 2019) Authors: Stone, John H.; Tuckwell, Katie; Dimonaco, Sophie; Klearman, Micki; Aringer, Martin; Blockmans, Daniel; Brouwer, Elisabeth; Cid, Maria C.; Dasgupta, Bhaskar; Rech, Juergen; Salvarani, Carlo; Schulze‐Koops, Hendrik; Schett, Georg; Spiera, Robert; Unizony, Sebastian H.; Collinson, Neil Journal: Arthritis & rheumatology Issue: Volume 71:Issue 8(2019) Page Start: 1329 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Humoral immune response to vaccines in patients with rheumatoid arthritis treated with tocilizumab: results of a randomised controlled trial (VISARA). Issue 5 (21st January 2014) Authors: Bingham, Clifton O; Rizzo, Warren; Kivitz, Alan; Hassanali, Azra; Upmanyu, Ruchi; Klearman, Micki Journal: Annals of the rheumatic diseases Issue: Volume 74:Issue 5(2015) Page Start: 818 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. O26 Effects of baseline prednisone dose on remission and disease flare in patients with giant cell arteritis treated with tocilizumab in the GiACTA trial. (12th April 2019) Authors: Stone, John H; Tuckwell, Katie; Dimonaco, Sophie; Klearman, Micki; Aringer, Martin; Blockmans, Daniel; Brouwer, Elisabeth; Cid, Maria C; Dasgupta, Bhaskar; Rech, Juergen; Salvarani, Carlo; Schulze-Koops, Hendrik; Schett, Georg; Spiera, Robert F; Unizony, Sebastian H; Collinson, Neil Journal: Rheumatology Issue: Volume 58(2019)Supplement 3 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗